About ImmunoChemistry
ImmunoChemistry is a company based in Bloomington (United States) founded in 1994. The company has 5 employees. ImmunoChemistry offers products and services including Primary Antibodies, ELISA Kits, and Cell Viability Assays. ImmunoChemistry operates in a competitive market with competitors including Abingdon Health, Olink, US BioTek Laboratories, Spear Bio and Eclipse Bio, among others.
- Headquarter Bloomington, United States
- Employees 5
- SectorsHealthcare
- Email••••••••
- Website immunochemistry.com
- Social LinkedIn X Facebook
- Legal Name Immunochemistry Technologies, Llc
- Latest Funding Round$497.41K (USD), Grant
Sep 2009
- Investors
- Employee Count5
Products & Services of ImmunoChemistry
ImmunoChemistry offers a comprehensive portfolio of products and services, including Primary Antibodies, ELISA Kits, and Cell Viability Assays.
Antibodies for detecting specific proteins in experiments
Kits for enzyme-linked immunosorbent assays in research
Assays to measure cell health and metabolic activity
Funding Insights of ImmunoChemistry
- Total Rounds 3
- Last Round Grant — $497,409
- First Round $746,063
(Sep 2008)
- Investors Count 1
All 3 funding rounds of ImmunoChemistry with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in ImmunoChemistry
ImmunoChemistry has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for ImmunoChemistry
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ImmunoChemistry
1 people are tracked at ImmunoChemistry (1 in leadership); the tracked headcount is 5.
| Name | Role | Group |
|---|---|---|
Kristen Pauly | Vice President Of BD & Marketing, Advisory Board Member | Leadership |
Complete people profiles for ImmunoChemistry
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ImmunoChemistry
3 dated milestones of ImmunoChemistry across 15 years, from founding to its latest funding, stage changes and deals.
- Founded ImmunoChemistry is founded.
- Funding First funding round of $746K.
- Funding Latest funding round, Grant, of $497K.
Competitors of ImmunoChemistry
ImmunoChemistry operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Olink, US BioTek Laboratories, Spear Bio and Eclipse Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abingdonhealth.com | 2008 | York, United Kingdom | $24.05M | 151 | Developer of immunoassays for diagnostic purposes | |
| olink.com | 2004 | Uppsala, Sweden | – | 138 | Provider of products and services for human protein biomarker research and development | |
| usbiotek.com | 2008 | Shoreline, United States | $19.5M | – | Provider of enzyme-linked immunosorbent assay technology services | |
| spear.bio | 2021 | Boston, United States | $48.96M | – | Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers | |
| eclipsebio.com | 2017 | San Diego, United States | $14M | 14 | Cell-free immunoassays are developed to identify RNA binding protein targets. | |
| virtuedx.com | 2019 | Suzhou, China | $130M | – | An in vitro assay platform is provided for diagnostic solutions. | |
| accellix.com | 2007 | San Jose, United States | $35.84M | – | Developer of immunotherapy-based assay delivery platform | |
| remedybiologics.com | 2017 | Dublin, Ireland | $9.43M | – | Personalized cell-based autologous therapies for anti-tumor applications are provided. | |
| orbitdiscovery.com | 2015 | Oxford, United Kingdom | $15.73M | 26 | Drug discovery platform developed using peptide display engine. |
Detailed competitors of ImmunoChemistry
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ImmunoChemistry
Websites that share an audience with ImmunoChemistry (immunochemistry.com).
Websites whose visitors overlap most with ImmunoChemistry. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abcam.com | 100% | 602.8K | #91,958 | View details | |
precisionantibody.com | precisionantibody.com | 98% | – | #3,295,457 | – |
| randox-lifesciences.com | 98% | – | – | View details | |
promokine.info | promokine.info | 96% | – | – | – |
| oxfordbiomed.com | 95% | 3.8K | #4,977,915 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for ImmunoChemistry
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to ImmunoChemistry
10 companies that operate in the same segment as ImmunoChemistry (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ImmunoChemistry
ImmunoChemistry was founded in 1994 and raised its 1st funding round 14 years after it was founded.
ImmunoChemistry is headquartered in Bloomington, United States. It is registered at Bloomington, Indiana, United States.
ImmunoChemistry has 5 employees.
Immunochemistry engages in manufacturing and research tools and offers laboratory services. The product portfolio of the companies include ELISA reagents such as Plates and Accessories, Coating Buffers, Blocking Buffers, Wash Buffer, Sample and Assay, Diluents, Conjugates and Stabilizers, Substrates, Stop Solutions, ELISA Development Kits, and recombinant proteins as ELISA standards.
ImmunoChemistry's top competitors include Abingdon Health, Eclipse Bio and Spear Bio.
ImmunoChemistry offers Primary Antibodies, ELISA Kits, and Cell Viability Assays.
ImmunoChemistry has 1 investor. Key investors include HHS.
ImmunoChemistry operates through Immunochemistry Technologies, Llc.